A Novel Immunocytolytic Factor Secreted by Pancreatic Adenocarcinoma

Author： Angel L.P. Divino C.M. Brower S.T. Chen S-H.

ISSN： 0022-4804

Source： Journal of Surgical Research, Vol.91, Iss.2, 2000-06, pp. : 154-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcome of Distal Pancreatectomy for Pancreatic Adenocarcinoma

Digestive Surgery, Vol. 25, Iss. 1, 2008-02 ,pp. : 32-38

Karger

Access to resources Recommend Favorite

Effect of Socioeconomic Status on Surgery for Pancreatic Adenocarcinoma

By Seyedin Steven Luu Carrie Stabile Bruce E. Lee Byrne

The American Surgeon, Vol. 78, Iss. 10, 2012-10 ,pp. : 1128-1131

Southeastern Surgical Congress

Access to resources Recommend Favorite

Benefit of venous resection for ductal adenocarcinoma of the pancreatic head

By Hartel Mark Niedergethmann Marco Farag-Soliman Michael Sturm Jörg Richter Axel Trede Michael Post Stefan

European Journal of Surgery, Vol. 168, Iss. 12, 2002-01 ,pp. : 707-712

Informa Healthcare

Access to resources Recommend Favorite

Activation of Raf-1 in Human Pancreatic Adenocarcinoma

By Berger D.H. Jardines L.A. Chang H. Ruggeri B.

Journal of Surgical Research, Vol. 69, Iss. 1, 1997-04 ,pp. : 199-204

Academic Press

Access to resources Recommend Favorite

Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma

Digestive Surgery, Vol. 33, Iss. 4, 2016-05 ,pp. : 343-350

Karger

Access to resources Recommend Favorite